Correction to: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome
| dc.contributor.author | Legault, Kimberly | |
| dc.contributor.author | Blostein, Mark | |
| dc.contributor.author | Carrier, Marc | |
| dc.contributor.author | Kahn, Susan | |
| dc.contributor.author | Schulman, Sam | |
| dc.contributor.author | Shivakumar, Sudeep | |
| dc.contributor.author | Wu, Cynthia | |
| dc.contributor.author | Crowther, Mark A | |
| dc.date.accessioned | 2020-05-24T03:46:19Z | |
| dc.date.available | 2020-05-24T03:46:19Z | |
| dc.date.issued | 2020-05-18 | |
| dc.date.updated | 2020-05-24T03:46:19Z | |
| dc.description.abstract | An amendment to this paper has been published and can be accessed via the original article. | |
| dc.identifier.citation | Pilot and Feasibility Studies. 2020 May 18;6(1):67 | |
| dc.identifier.uri | https://doi.org/10.1186/s40814-020-00614-0 | |
| dc.identifier.uri | https://doi.org/10.20381/ruor-24772 | |
| dc.identifier.uri | http://hdl.handle.net/10393/40541 | |
| dc.language.rfc3066 | en | |
| dc.rights.holder | The Author(s) | |
| dc.title | Correction to: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome |
